RPL14 Antikörper (AA 1-135)
Kurzübersicht für RPL14 Antikörper (AA 1-135) (ABIN2800685)
Target
Alle RPL14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-135
-
Verwendungszweck
- RPL14 antibody [N1C1], 0.69 mg/ml
-
Immunogen
- Recombinant fragment corresponding to a region within amino acids 1-135 of RPL14
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Tested Western blot
Application Notes
Suggested starting dilutions are as follows: WB: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.Sample (30 μg of whole cell lysate) A: 293T 12 % SDS PAGE 107-10012 diluted at 1:1000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.69 mg/mL
-
Buffer
- 0.1M Tris, 0.1M Glycine, 10 % Glycerol ( pH 7). 0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- RPL14 (Ribosomal Protein L14 (RPL14))
-
Andere Bezeichnung
- RPL14
-
Molekulargewicht
- 23 kDa
-
Gen-ID
- 9045
Target
-